Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 2,685.85 | 522.09 | 390.78¢ | 33.6 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,090.70 | 780.70 | 597.65¢ | 22.0 | 0.4 | +53% | n/a | 0.0% |
31-Dec-27 | 3,460.04 | 1,035.39 | 815.95¢ | 16.1 | 0.4 | +36% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Also | 24-Jun-2006 | LA Times |
Also | 17-May-2006 | LA Times |
F.D.A. Demurs on Sleep Drug by Neurocrine | 17-May-2006 | New York Times |
Currency | US Dollars |
Share Price | $ 132.90 |
Change Today | $ 1.59 |
% Change | 1.21 % |
52 Week High | $152.81 |
52 Week Low | $93.25 |
Volume | 558,515 |
Shares Issued | 91.27m |
Market Cap | $12,129m |
RiskGrade | 225 |
Strong Buy | 11 |
Buy | 11 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 26 |
Time | Volume / Share Price |
16:00 | 600 @ $132.90 |
16:00 | 89,146 @ $132.90 |
15:59 | 200 @ $132.90 |
15:59 | 271 @ $132.90 |
15:59 | 222 @ $132.90 |
You are here: research